Euroapi is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world.
We are a world leader in active pharmaceutical ingredients with some 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO).
2021
Served areaWorldwide
Headcount3,350
Headquarters15 Rue Traversière, 75012 Paris – France
94,026,888
IPOMay 6, 2022
Stock exchange(s)Euronext Paris